Medical Equipment

Rising Prevalence Of Respiratory Diseases Fuels Growth In The Dry Powder Inhaler Market Is Contributing To Changes In The Dry Powder Inhaler Market

April 10, 2026April 15, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Changes In Market Value Are Expected For The Dry Powder Inhaler Market Over The 2026–2030 Period?

The dry powder inhaler market has experienced consistent growth over the last few years. This market is projected to expand from $22.18 billion in 2025 to reach $23.25 billion by 2026, exhibiting a compound annual growth rate (CAGR) of 4.8%. Historically, this expansion has been driven by factors such as a rising incidence of asthma and COPD, the extensive adoption of inhalation therapy, advancements in dry powder formulation techniques, the growth of home-based respiratory care options, and the accessibility of cost-effective inhaler devices.

The dry powder inhaler market is projected to experience consistent expansion over the upcoming years. This market is forecast to reach a valuation of $28.16 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 4.9%. Factors driving this growth during the forecast period include the expanding integration of smart inhaler technologies, a heightened emphasis on personalized respiratory care, the broader adoption of remote patient monitoring, an escalating demand for eco-friendly inhalers, and the increasing incorporation of digital health ecosystems. Key trends anticipated in the forecast period encompass a surge in the adoption of digitally operated inhalers, an escalating need for patient-adherence monitoring, an intensified focus on designs that are both portable and user-friendly, the proliferation of multi-dose inhaler platforms, and an amplified emphasis on ensuring dose accuracy.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13430&type=smp

Which Important Drivers Are Guiding The Dry Powder Inhaler Market Growth?

The increasing incidence of respiratory ailments is anticipated to drive expansion in the dry powder inhaler market moving ahead. These diseases are defined as pulmonary or breathing-related disorders, encompassing a wide array of health issues impacting the respiratory system. Dry powder inhalers play a crucial role in managing conditions like asthma, COPD, and cystic fibrosis by delivering medication directly to the lungs, ensuring maximum efficacy. They offer a viable alternative to conventional drug administration techniques for treating respiratory illnesses. As an illustration, a research study published in December 2023 by JAMA Network Open, a medical journal from the American Medical Association, indicated that the global caseload for chronic obstructive pulmonary disease (COPD) is projected to reach almost 600 million by 2050 globally, representing a 23% rise in its occurrence. Consequently, the rising occurrence of respiratory conditions will fuel the dry powder inhaler market’s growth.

What Segment Categories Shape The Dry Powder Inhaler Market Segment Landscape?

The dry powder inhaler market covered in this report is segmented –

1) By Product: Single-Dose Inhalers, Multi-Dose Inhalers

2) By Function: Manually Operated Inhaler Devices, Digitally Operated Inhaler Devices

3) By Application: Asthma, Chronic Obstructive Pulmonary Disease (COPD), Cystic Fibrosis, Other Applications

4) By End User: Hospitals And Clinics, Homecare Settings, Ambulatory Surgical Centers, Other End Users

Subsegments:

1) By Single-Dose Inhalers: Capsule-Based Inhalers, Diskus-Based Inhalers

2) By Multi-Dose Inhalers: Blister-Based Inhalers, Rotahaler-Based Inhalers

What Trends Are Influencing The Evolution Of The Dry Powder Inhaler Market?

Leading companies within the dry powder inhaler market are actively developing innovative products featuring muscarinic antagonists to treat chronic obstructive pulmonary disease (COPD) and expand their product offerings. A muscarinic antagonist is a pharmaceutical agent that inhibits the muscarinic acetylcholine receptor, effectively managing and treating various conditions such as COPD and organophosphate poisoning. For instance, in March 2024, Berry Global, a US-based company renowned for its development and manufacturing of diverse flexible packaging solutions, launched its new dry powder inhaler at Pharmapack, signaling a strategic move into advanced drug-delivery technologies. This device is engineered to improve the efficiency and consistency of drug delivery for respiratory conditions, especially COPD and asthma, where precise dosing and ease of use are paramount. Its customizable design enables pharmaceutical companies to adapt the inhaler to specific formulation requirements, thereby offering greater flexibility in product development. By combining patient-centric functionality with adaptable characteristics, Berry Global aims to foster innovation in the respiratory therapeutics sector while reinforcing its role as a partner for pharmaceutical manufacturers.

Who Are The Companies Operating Across The Dry Powder Inhaler Market Value Chain?

Major companies operating in the dry powder inhaler market are Novartis AG, AstraZeneca plc., GlaxoSmithKline Plc, Boehringer Ingelheim GmbH, Viatris (Mylan N.V), Otsuka Pharmaceutical Co. Ltd, Catalent Inc., Aptar Group Inc., Chiesi Farmaceutici S.p.A., Recipharm AB, Cipla Limited, Lupin Limited, Orion Corporation, Hovione, MannKind Corporation, Presspart Manufacturing Ltd, Teva Pharmaceutical Industries Limited, Pharmaxis Ltd., Iconovo AB, SRS Pharmaceuticals Pvt. Ltd.

Get The Full Dry Powder Inhaler Market Report:

https://www.thebusinessresearchcompany.com/report/dry-powder-inhaler-global-market-report

Where Is The Dry Powder Inhaler Market Most Concentrated Geographically?

North America was the largest region in the dry powder inhaler market in 2025. The regions covered in the dry powder inhaler market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Dry Powder Inhaler Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/customise?id=13430&type=smp

Browse Through More Reports Similar to the Global Dry Powder Inhaler Market 2026, By The Business Research Company

Digital Dose Inhalers Market Report 2026

https://www.thebusinessresearchcompany.com/report/digital-dose-inhalers-global-market-report

Inhalation And Nasal Spray Generic Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/inhalation-and-nasal-spray-generic-drugs-global-market-report

Respiratory Inhaler Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/respiratory-inhaler-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795